Search Results - Juan Gonzalez‐Maffe

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia

    Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia by Tricia Tan, Benjamin Field, Katherine McCullough, R. Troke, Edward S. Chambers, Victoria Salem, Juan Gonzalez Maffe, Kevin Baynes, Akila De Silva, Alexander Viardot, Ali Alsafi, Gary Frost, Mohammad A. Ghatei, Stephen R. Bloom

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage

    Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage by Channa Jayasena, Ali Abbara, Chioma Izzi‐Engbeaya, Alexander Comninos, Richard Harvey, Juan Gonzalez Maffe, Zubair Sarang, Zainab Ganiyu‐Dada, Ana Padilha, M. Dhanjal, Catherine Williamson, L. Regan, Mohammad A. Ghatei, Stephen R. Bloom, Waljit S. Dhillo

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women

    Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women by Rufus Cartwright, Anna C. Kirby, Kari A.O. Tikkinen, Altaf Mangera, Gans Thiagamoorthy, Prabhakar Rajan, Jori S. Pesonen, Chris Ambrose, Juan Gonzalez‐Maffe, Phillip R. Bennett, Tom Palmer, Andrew J. Walley, Marjo‐Riitta Järvelin, Christopher R. Chapple, Vik Khullar

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma

    A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma by Sophie Piperno‐Neumann, Matteo S. Carlino, Valentina Boni, D. Loirat, Frank M. Speetjens, John Park, Emiliano Calvo, Richard D. Carvajal, M. Nyakas, Juan Gonzalez‐Maffe, Xiaobo Zhu, Matthew D. Shirley, Thiruvamoor Ramkumar, A. Fessehatsion, Hannah Burks, Padmaja Yerramilli-Rao, Ellen Kapiteijn

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

    Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer by Caroline Even, Hung‐Ming Wang, Shau-Hsuan Li, Roger K.C. Ngan, Arunee Dechaphunkul, Li Zhang, Chia‐Jui Yen, Po Chung Chan, Somvilai Chakrabandhu, Brigette Ma, Suebpong Tanasanvimon, Victor Lee, Pei‐Jen Lou, Zujun Li, Alexander I. Spira, Ammar Sukari, J. Guigay, Steven McCune, Juan Gonzalez‐Maffe, Sebastian Szpakowski, Yao Yao, Hongzi Liang, Jennifer Mataraza, Romain Séchaud, Luigi Manenti, Wan‐Teck Lim

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: